Steven B. Brugger

2009

In 2009, Steven B. Brugger earned a total compensation of $967.6K as Former Chief Operating Officer at Momenta Pharmaceuticals, a 29% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,644
Option Awards$291,226
Salary$369,178
Stock Awards$180,700
Other$9,890
Total$967,638

Brugger received $369.2K in salary, accounting for 38% of the total pay in 2009.

Brugger also received $116.6K in non-equity incentive plan, $291.2K in option awards, $180.7K in stock awards and $9.9K in other compensation.

Rankings

In 2009, Steven B. Brugger's compensation ranked 4,573rd out of 9,885 executives tracked by ExecPay. In other words, Brugger earned more than 53.7% of executives.

ClassificationRankingPercentile
All
4,573
out of 9,885
54th
Division
Manufacturing
1,629
out of 3,690
56th
Major group
Chemicals And Allied Products
326
out of 871
63rd
Industry group
Drugs
198
out of 643
69th
Industry
Biological Products, Except Diagnostic Substances
35
out of 138
75th
Source: SEC filing on April 26, 2011.

Brugger's colleagues

We found six more compensation records of executives who worked with Steven B. Brugger at Momenta Pharmaceuticals in 2009.

2009

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2009

James Roach

Momenta Pharmaceuticals

Chief Medical Officer

2009

John Bishop

Momenta Pharmaceuticals

Senior Vice President, Pharmaceutical Sciences

2009

Ganesh Venkataraman

Momenta Pharmaceuticals

Chief Scientific Officer

2009

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Scientific Officer

2009

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like